Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Mallinckrodt
Queensland Health
Argus Health
Cerilliant
Healthtrust
Covington
Teva
Express Scripts
AstraZeneca

Generated: July 21, 2018

DrugPatentWatch Database Preview

Chloroquine phosphate; primaquine phosphate - Generic Drug Details

see a sample report or, see our see our flat-rate plans

« Back to Dashboard

What are the generic sources for chloroquine phosphate; primaquine phosphate and what is the scope of chloroquine phosphate; primaquine phosphate patent protection?

Chloroquine phosphate; primaquine phosphate
is the generic ingredient in one branded drug marketed by Sanofi Aventis Us and is included in one NDA. Additional information is available in the individual branded drug profile pages.

There are twenty drug master file entries for chloroquine phosphate; primaquine phosphate.
Summary for chloroquine phosphate; primaquine phosphate
US Patents:0
Tradenames:1
Applicants:1
NDAs:1
Drug Master File Entries: 20
Clinical Trials: 15
DailyMed Link:chloroquine phosphate; primaquine phosphate at DailyMed

US Patents and Regulatory Information for chloroquine phosphate; primaquine phosphate

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Sanofi Aventis Us ARALEN PHOSPHATE W/ PRIMAQUINE PHOSPHATE chloroquine phosphate; primaquine phosphate TABLET;ORAL 014860-002 Approved Prior to Jan 1, 1982 DISCN No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

see a sample report or, see our see our flat-rate plans

see a sample report or, see our see our flat-rate plans

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

US Department of Justice
Queensland Health
Cerilliant
UBS
Dow
Teva
Mallinckrodt
Harvard Business School
AstraZeneca

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.